RecruitingPhase 4

MAPS PrEP Van Study

United States20 participantsStarted 2025-09-17

Plain-language summary

For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program Exclusion Criteria: * positive HIV status

What they're measuring

Enrollment

Timeframe: Baseline

Negative HIV Status

Timeframe: up to 3 months

PrEP Consultation

Timeframe: up to 6 months

PrEP Initiation

Timeframe: up to 6 months

Retention

Timeframe: up to 6 months

Follow Through

Timeframe: up to 6 months

Negative HIV Status at 6 months

Timeframe: up to 6 months

Trial details

NCT IDNCT06908252

SponsorDuke University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-30

Contact for this trial

Amelia R Ashkin-Baker, BA

(919)448-8680 amelia.ashkin-baker@duke.edu

View on ClinicalTrials.gov More HIV Infection trials